Cargando…

A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19

OBJECTIVE: To objectively evaluate the efficacy of the Zilongjin tablets in non-small cell lung cancer (NSCLC) and to explore its potential mechanism of action against NSCLC and COVID-19 based on network pharmacology. METHODS: The database was searched for randomized controlled trials (RCTs) of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wuxia, Zhang, Yichao, Gao, Jing, Hu, Pengcheng, Yang, Yanjie, Xu, Xiaoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427870/ https://www.ncbi.nlm.nih.gov/pubmed/37593408 http://dx.doi.org/10.3389/fmed.2023.1080121

Ejemplares similares

Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation
por: Ding, Rongzhen, et al.
Publicado: (2021)

Clinical Laboratory Results as Prognosis Marker in Advanced Stage Non-small Cell Lung Cancer (NSCLC) in Indonesia
por: Hanafi, Arif R, et al.
Publicado: (2022)

Focus on Nivolumab in NSCLC
por: Cortinovis, Diego L., et al.
Publicado: (2016)

Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach
por: Rao, Yifei, et al.
Publicado: (2023)

Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: A systematic review and meta-analysis
por: Shi, Jinghua, et al.
Publicado: (2022)

Efficacy of Mecobalamin Tablets Combined with Troxerutin in the Treatment of NSCLC Chemotherapy-Induced Peripheral Neuropathy
por: Li, Yang, et al.
Publicado: (2022)

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
por: Passaro, Antonio, et al.
Publicado: (2021)

Focus on Nintedanib in NSCLC and Other Tumors
por: Manzo, Anna, et al.
Publicado: (2016)

Comparison of oral sodium phosphate tablets and polyethylene glycol lavage solution for colonoscopy preparation: a systematic review and meta-analysis of randomized clinical trials
por: Yao-dong, Li, et al.
Publicado: (2023)

Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials
por: Wang, Qinxue, et al.
Publicado: (2016)

Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease
por: Lin, Tong, et al.
Publicado: (2021)

Staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2006)

Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival
por: Wang, Zhaoxi, et al.
Publicado: (2015)

The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking
por: Du, Lin, et al.
Publicado: (2022)

Metabolomics unveils the mechanism of Bufei Huayu decoction in combination with cisplatin against non-small cell lung cancer (NSCLC)
por: Feng, Yuan, et al.
Publicado: (2023)

Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach
por: Ma, Xiaoqin, et al.
Publicado: (2020)

A Network Pharmacology Study: Reveal the Mechanisms of Palovarotene Against Heterotopic Ossification
por: Huang, Junchao, et al.
Publicado: (2022)

Ghost tablet in feces
por: Iwamuro, Masaya, et al.
Publicado: (2017)

Two Cases of SMARCA4-Deficient Non-small Cell Lung Cancer (NSCLC) with Improved Performance Status (PS) after Treatment with Immune Checkpoint Inhibitors (ICIs)
por: Koizumi, Akiko, et al.
Publicado: (2023)

Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept
por: Berghmans, Thierry, et al.
Publicado: (2020)

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients
por: Yin, Ji-Ye, et al.
Publicado: (2012)

ALK‐rearrangement in non‐small‐cell lung cancer (NSCLC)
por: Du, Xue, et al.
Publicado: (2018)

Determination of the synergistic anti-influenza effect of Huangqin Su tablet and Oseltamivir and investigation of mechanism of the tablet based on gut microbiota and network pharmacology
por: Cui, Xuran, et al.
Publicado: (2023)

Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Yang, Yan-Long, et al.
Publicado: (2014)

Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015)

Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivo
por: Zhao, Honglin, et al.
Publicado: (2015)

Efficacy and safety of nab-paclitaxel plus platinum in non-small cell lung cancer: a meta-analysis
por: Tan, Tianying, et al.
Publicado: (2023)

Treatment of liver fibrosis in hepatolenticular degeneration with traditional Chinese medicine: systematic review of meta-analysis, network pharmacology and molecular dynamics simulation
por: Yang, Xulong, et al.
Publicado: (2023)

Mycobacteremia from Crushed Hydromorphone Tablet Injection
por: Banno, Joseph M, et al.
Publicado: (2017)

Based on Network Pharmacology Tools to Investigate the Mechanism of Tripterygium wilfordii Against IgA Nephropathy
por: Xia, Ming, et al.
Publicado: (2021)

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wu, Qiang, et al.
Publicado: (2021)

Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC
por: Tran, Phu N., et al.
Publicado: (2016)

Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis
por: Mao, WeiLi, et al.
Publicado: (2023)

Real‐world treatment and prognostic factors for survival in ALK+ non‐small cell lung cancer (NSCLC) patients with brain metastases in China
por: Li, Na, et al.
Publicado: (2022)

Advances in radiological staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2004)

ASCO 2020 non-small lung cancer (NSCLC) personal highlights
por: Horvath, Lena, et al.
Publicado: (2021)

An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
por: Murphy, Ciara, et al.
Publicado: (2023)

Molecular mechanism of vitiligo treatment by bailing tablet based on network pharmacology and molecular docking
por: Li, Jinming, et al.
Publicado: (2022)

Efficacy of small-incision lenticule extraction surgery in high astigmatism: A meta-analysis
por: Cui, Ge, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oonea6ofle9rckalh120b5bate